Abstract

Microbial Ni2+ homeostasis underpins the virulence of several clinical pathogens. Ni2+ is an essential cofactor in urease and [NiFe]-hydrogenases involved in colonization and persistence. Many microbes produce metallophores to sequester metals necessary for their metabolism and starve competing neighboring organisms. The fungal metallophore aspergillomarasmine A (AMA) shows narrow specificity for Zn2+, Ni2+, and Co2+. Here, we show that this specificity allows AMA to block the uptake of Ni2+ and attenuate bacterial Ni-dependent enzymes, offering a potential strategy for reducing virulence. Bacterial exposure to AMA perturbs H2 metabolism, ureolysis, struvite crystallization, and biofilm formation and shows efficacy in a Galleria mellonella animal infection model. The inhibition of Ni-dependent enzymes was aided by Zn2+, which complexes with AMA and competes with the native nickelophore for the uptake of Ni2+. Biochemical analyses demonstrated high-affinity binding of AMA-metal complexes to NikA, the periplasmic substrate-binding protein of the Ni2+ uptake system. Structural examination of NikA in complex with Ni-AMA revealed that the coordination geometry of Ni-AMA mimics the native ligand, Ni-(l-His)2, providing a structural basis for binding AMA-metal complexes. Structure-activity relationship studies of AMA identified regions of the molecule that improve NikA affinity and offer potential routes for further developing this compound as an anti-virulence agent.

Aspergillomarasmine A (AMA) chelates metal ions such as Zn2+ and Ni2+, which are essential for the activity of enzymes that are important for virulence of several pathogens. Here, Sychantha et al. show that AMA inhibits bacterial Ni2+ uptake and Ni-dependent enzymes, and reduces bacterial virulence in an animal infection model.

Details

Title
Targeting bacterial nickel transport with aspergillomarasmine A suppresses virulence-associated Ni-dependent enzymes
Author
Sychantha, David 1 ; Chen, Xuefei 2 ; Koteva, Kalinka 2   VIAFID ORCID Logo  ; Prehna, Gerd 3   VIAFID ORCID Logo  ; Wright, Gerard D. 2   VIAFID ORCID Logo 

 McMaster University, David Braley Centre for Antibiotic Discovery, Hamilton, Canada (GRID:grid.25073.33) (ISNI:0000 0004 1936 8227); McMaster University, M.G. DeGroote Institute for Infectious Disease Research, Hamilton, Canada (GRID:grid.25073.33) (ISNI:0000 0004 1936 8227); McMaster University, Department of Biochemistry and Biomedical Sciences, Hamilton, Canada (GRID:grid.25073.33) (ISNI:0000 0004 1936 8227); University of Waterloo, Department of Chemistry, Waterloo, Canada (GRID:grid.46078.3d) (ISNI:0000 0000 8644 1405) 
 McMaster University, David Braley Centre for Antibiotic Discovery, Hamilton, Canada (GRID:grid.25073.33) (ISNI:0000 0004 1936 8227); McMaster University, M.G. DeGroote Institute for Infectious Disease Research, Hamilton, Canada (GRID:grid.25073.33) (ISNI:0000 0004 1936 8227); McMaster University, Department of Biochemistry and Biomedical Sciences, Hamilton, Canada (GRID:grid.25073.33) (ISNI:0000 0004 1936 8227) 
 University of Manitoba, Department of Microbiology, Winnipeg, Canada (GRID:grid.21613.37) (ISNI:0000 0004 1936 9609) 
Pages
4036
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3054303315
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.